| Literature DB >> 33192661 |
Chara Ioannou1, Divya Seernani1, Maria Elena Stefanou1,2, Andreas Riedel3, Ludger Tebartz van Elst3, Nikolaos Smyrnis4, Christian Fleischhaker1, Monica Biscaldi-Schaefer1, Giuseppe Boccignone5, Christoph Klein1,4,6.
Abstract
Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) represent two common neurodevelopmental disorders with considerable co-occurrence. Their comorbidity (ASD + ADHD) has been included in the latest diagnostic guidelines (DSM-V, 2013). The present study focuses on social visual attention that i) is a main aspect of social attention reflecting social cognition and ii) its atypicalities have been suggested as a potential biomarker for ASD. Considering the possible shared background of both disorders and their comorbidity, it is important to compare such traits directly. Here, 73 children and adolescents paired for age and IQ diagnosed with ASD (N = 12), ADHD (N = 21), comorbid ASD + ADHD (N = 15), and "typically developing" (TD) controls (N = 25), were shown static real-life social scenes while their gaze movements were recorded with eye-tracking. Scenes with two levels of social complexity were presented: low complexity (one person depicted) and high (four interacting individuals). Gaze fixation variables were investigated. Fixation duration on faces was significantly reduced only in ASD + ADHD which also required longer time to fixate all faces at least once. Fixation duration on faces in ASD was reduced, compared to TD, only when looking at scenes with high versus low social complexity. ADHD individuals did not differ from TD. Concluding, the observed alterations of social visual attention support the existence of possible dysfunctional particularities differentiating ASD, ADHD, and ASD + ADHD, which can be revealed with the new method of eye-tracking technique. The objective gaze measurements provided contribute to the development of biomarkers enabling early diagnosis, amelioration of care and further interventions specified for each group.Entities:
Keywords: attention-deficit/hyperactivity disorder; autism spectrum disorder; comorbidity; eye tracking; neurodevelopmental disorders; social cognition
Year: 2020 PMID: 33192661 PMCID: PMC7555692 DOI: 10.3389/fpsyt.2020.545567
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Demographics, assessment and diagnostic scoring of the distinct groups.
| Variable | TD | ADHD | ASD | ASD + ADHD | Statistical inference | ||
|---|---|---|---|---|---|---|---|
| Hypothesis testing | contrasts | ||||||
| Number of participants | 25 | 21 | 12 | 15 | – | – | |
| Males (in %) | 52 | 76 | 83 | 93 | χ2 = 9.4 | – | |
| Age in years | 12.1 ± 1.5 | 12.6 ± 0.9 | 12.3 ± 1.1 | 12 ± 1.0 | p = 0.48 | – | |
| IQ | 110 ± 17 | 102 ± 13 | 103 ± 21 | 96 ± 15 | p = 0.07 | – | |
| Education level | 8, 0, 40, 52 | 0, 10, 76, 14 | 8, 25,42,25 | 20, 7, 7, 66 | |||
| Social training (in %) | – | – | 50 | 40 | χ2 = 0.02 | ||
| CBCL-total problems | 50 ± 6.6 | 64.9 ± 7.9 | 68.1 ± 8.3 | 64.7 ± 8.5 | p <.001 | TD < ADHD, ASD, ASD + ADHD | |
| SRS-total | 44.2 ± 8.7 | 66.6 ± 10 | 76.6± 13.4 | 77.0 ± 8.4 | p <.001 | TD < ADHD < ASD, ASD + ADHD | |
| ADHD symptomatology | |||||||
| EAQ-total | – | 7.1 ± 1.1 | 6.6 ± 1.1 | 7.2 ± 0.9 | p = 0.28 | – | |
| EAQ-Competence* | – | 3.4 ± 1.2 | 4.8 ± 1.6 | 4.1 ± 1.4 | p = 0.02 | ADHD < ASD | |
| SAQ-total | – | 6.3 ± 1.8 | 5.5 ± 1.6 | 6.8 ± 1.3 | p = 0.13 | – | |
| SAQ-Competence* | – | 4.9 ± 1.8 | 5.8 ± 1.1 | 5.3 ± 1.7 | p = 0.29 | – | |
| ADOS total score | – | – | 12.6 ± 4.9 (10–17) | 10.2 ± 4.3 (7–13) | |||
| ADI-R interaction | – | – | 12.6 ± 4.9 (10–17) | 12.6 ± 4.9 (10–17) | |||
| ADI-R communication | – | – | 13.8 ± 5.1 (11–14) | 15.6 ± 7.6 (10–22) | |||
| ADI-R restricted and repetitive behavior | – | – | 5.2 ± 2.9 (8–13) | 4.8 ± 3.1 (3–6) | |||
| Permanent medication (count) | – | MPH 12† | AAP 1 | AAP 2, MPH 6† | |||
Values correspond to group mean ± 1 standard deviation, while 25th percentile and 75th percentile are inside parentheses, if not stated otherwise. All scores for CBCL and SRS are T-scores, while all scores for EAQ and SAQ are Stanine scores. #Education level is categorical (1: primary school, 2a–c: secondary level, lowest to highest sublevels). *Higher competence scores are associated with normal functioning. †Medication had been discontinued at the day of the experiment. Abbreviations: TD, Typically Developing; ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; ASD + ADHD, comorbid group with ASD and ADHD; χ2, chi-squared; p, p-value; “<“ and “>“ symbols indicate statistically significant contrasts; CBCL, Child Behavior Checklist; SRS, Social Responsiveness Scale; EAQ and SAQ, External- and Self-assessment Questionnaires for ADHD, respectively, based on ICD-10, DSM-V (39); ADOS, Autism Diagnostic Observation Schedule; ADI-R, Autism Diagnostic Interview-Revised; MPH, methylphenydate; AAP, atypical antipsychotics.
Figure 1Heatmaps representing the amount of fixation duration for each group and stimuli of high and low social complexity. The warmer the color of the superimposed heatmap, the higher the fixation duration, while the scale is common for all subfigures. The ASD + ADHD group looks on average less at faces in both levels of social complexity, while ASD participants look less at faces when looking at the social complex picture with four interacting people rather than in the picture of low social complexity with one face only. The ADHD participants look at faces similar to TD. Abbreviations: TD, Typically Developing; ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; ASD + ADHD, Autism Spectrum Disorder with comorbid Attention-Deficit/Hyperactivity Disorder.
Fixed effects parameter estimates for fixation duration on faces from 73 subjects.
| Fixed effect | F value | Effect | Estimate | 95% CI | SE | p-value | |
|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||
| (Intercept) | 14.4 | 13.5 | 15.3 | 0.5 | <.001 | ||
| 4.65 | |||||||
| - ADHD vs. TD | −0.3 | −2.1 | 1.4 | 0.9 | 0.717 | ||
| - ASD vs. TD | 2 | −0.4 | 4.3 | 1.2 | 0.102 | ||
| - ASD + ADHD vs. TD | −2.3 | −4.5 | −0.2 | 1.1 | 0.032 | ||
| 4.75 | |||||||
| ADHD vs. TD × high vs. low | −0.9 | −3.4 | 1.6 | 1.3 | 0.493 | ||
| ASD vs. TD × high vs. low | −4.9 | −7.8 | −1.9 | 1.5 | 0.001 | ||
| ASD + ADHD vs. TD × high vs. low | 1.0 | −1.8 | 3.7 | 1.4 | 0.480 | ||
| 662.98 | high vs. low | −13.7 | −14.7 | −12.6 | 0.5 | <.001 | |
| 28.64 | (covariate) | 0.1 | 0.1 | 0.2 | 0.03 | <.001 | |
| 1.59 | yes vs. no | 1.3 | −0.7 | 3.4 | 1.1 | 0.212 | |
TD, Typically Developing; ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; ASD + ADHD, comorbid group with ASD and ADHD; CI, Confidence Interval; SE, Standard Error; vs., versus; x, interaction between two effects.
Figure 2Results of the mixed effects analysis for the region of faces. Mean estimates of the fixed effects with 95% confidence interval are shown as center and border lines of each box, respectively. Their position on the x-axis (in seconds) relative to 0 is a measure of the statistical effect on the fixation duration to faces. Two fixed effects significantly reduce the fixation duration to faces, namely, the ASD + ADHD and the interaction term of ASD x high social complexity. Color coding is explained in the legend. *p < 0.05, **p < 0.01. Abbreviations: TD, Typically Developing; ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; ASD + ADHD, Autism Spectrum Disorder with comorbid Attention-Deficit/Hyperactivity Disorder; hsc, high social complexity; x, interaction between two effects.